Abstract
All horses diagnosed with duodenitis/proximal jejunitis (DPJ) at the Texas Veterinary Medican Center between January 1, 1987 and July 1, 1993 were included in a retrospective study to evaluate the therapeutic and prognostic value of bethanechol and metoclopramide as gastrointestinal prokinetic drugs in horses with DPJ treated at our clinic, and to compare the clinical outcome of horses with DPJ treated with these drugs and those with DPJ that were not treated. During the study period, 70 horses diagnosed with DPJ were admitted to the clinic. Of these 70 horses, 18(25.7%) were treated with bethanechol, metoclopramide, or both; 13 of the 18 treated horses received more than one dose of either drug. No adverse effects of treatment with these drugs were noted. A precise therapeutic plan and clinical benefit of bethanechol, metoclopramide, or both coul not be determined from this retrospective study. The use of these gastrointestinal prokinetic drugs in horses with DPJ appeared to have prognostic value. Horses that did not respond to treatment with these gastrointestinal prokinetic drugs within 24 hours were not discharged alive.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
